CWC2024: New Frontiers in Oncology Research and Practice
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 12 December 2024 | Viewed by 491
Special Issue Editor
Interests: cancer therapy; cancer biomarker; neurogenomics; systems biology; intercellular communication; neurotransmission
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Continuing its success story, the Cancer World Congress (CWC) arrived at the 8th edition, will be organized in the wonderful city Dubrovnik from Croatia, on May 29-31, 2024. This Special Issue of Cancers will publish selected papers from the best CWC 2024 presentations that attracted the most interest of the audience, were particularly innovative and passed a rigorous peer-reviewing process. Owing to the generous theme "New Frontiers in Oncology Research and Practice", the 2024 CWC brings together leading experts in both cancer research and clinical oncology whose contributing papers will make a must have Cancers Special Issue. The publications will present novel ideas, research findings and improved practice from the very technical cancer bioinformatics and cancer genomics to cancer biology as it occurs in various organs, from cancer classical radio- and chemotherapy to modern immunotherapy and precision medicine, and from prevention and palliative care to social aspects of coping with cancer.
Dr. Dumitru A. Iacobas
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer bioinformatics
- cancer biology
- cancer diagnosis
- cancer genomics
- cancer immunotherapy
- corona virus and cancer
- cancer molecular mechanisms
- organ-specific cancers
- palliative cancer care
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
